High-sensitive C-reactive protein and dual antiplatelet in intracranial arterial stenosis

0 / 5 (0 votos)

Neurology Journal 

Fecha de publicación: 12 January 2018

DOI: DOI: https://doi.org/10.1212/WNL.0000000000004928

Autores: Jiejie LiAnxin WangXingquan ZhaoLiping LiuXia MengJinxi LinJing JingXinying ZouYilong Wang and Yongjun Wang

Background: To determine the relationship of high-sensitive C-reactive protein (hsCRP) and the efficacy and safety of dual antiplatelet therapy in patients with and without intracranial arterial stenosis (ICAS) in the Clopidogrel in High-Risk Patients with Acute Non-disabling Cerebrovascular Events (CHANCE) trial.